Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126456592 | 12645659 | 2 | F | 2015 | 20160907 | 20160811 | 20160909 | PER | US-GLAXOSMITHKLINE-US2016108548 | GLAXOSMITHKLINE | 0.00 | M | Y | 0.00000 | 20160909 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126456592 | 12645659 | 1 | PS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), 1D | U | 6ZP4560 | 203975 | 1 | DF | INHALATION POWDER | QD | ||||
| 126456592 | 12645659 | 2 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | U | 203975 | INHALATION POWDER | ||||||||||
| 126456592 | 12645659 | 3 | SS | FLOVENT DISKUS | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | 6ZP4888 | 0 | 1 | DF | INHALATION POWDER | BID | |||||
| 126456592 | 12645659 | 4 | SS | FLOVENT DISKUS | FLUTICASONE PROPIONATE | 1 | 0 | INHALATION POWDER | |||||||||||
| 126456592 | 12645659 | 5 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 6 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 8 | C | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 9 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 10 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 11 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 12 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 13 | C | Sumatriptan (Sumatriptan succinate) | SUMATRIPTAN SUCCINATE | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 14 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126456592 | 12645659 | 15 | C | TRAMADOL. | TRAMADOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126456592 | 12645659 | 1 | Ex-tobacco user |
| 126456592 | 12645659 | 2 | Dyspnoea |
| 126456592 | 12645659 | 3 | Ex-tobacco user |
| 126456592 | 12645659 | 4 | Chronic obstructive pulmonary disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126456592 | 12645659 | Burning sensation | |
| 126456592 | 12645659 | Drug ineffective | |
| 126456592 | 12645659 | Dyspnoea | |
| 126456592 | 12645659 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126456592 | 12645659 | 1 | 2015 | 0 | ||
| 126456592 | 12645659 | 3 | 2015 | 0 |